Answers are grounded in this paper and cite their sources.
The fraction of human serum designated as C'1 esterase inhibitor is known to inhibit the action of C'1 esterase, a plasma kallikrein, and PF/Dil, an enzyme in plasma enhancing cutaneous vascular permeability. In the present study, C'1 esterase inhibitor has been found to block the actions of plasmin and the C'1r subcomponent of the first component of complement, and to retard the generation of PF/Dil. No inhibition of blood clotting or of the generation of plasmin was demonstrable.
No takes yet. Share an insight, caveat, or question.
Ratnoff et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: